» Articles » PMID: 9037058

Highly Purified CD25- Resting T Cells Cannot Be Infected De Novo with HIV-1

Overview
Specialty Science
Date 1997 Feb 18
PMID 9037058
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have demonstrated that the expression of CD25 can distinguish CD25- latently infected cells from CD25+ cells actively producing virus. Our studies were designed to characterize the nature and stability of the viral genome in CD25- quiescent HIV-1-infected cells and to determine whether these cells could be infected de novo with HIV-1. Our results show that: (i) When unfractionated peripheral blood mononuclear cells are first infected with HIV-1 and the CD25- cells then isolated, the latter contain only incomplete DNA transcripts and no full-length DNA or 2-LTR circles. Phytohemagglutinin activation of these CD25- cells results in the generation of full-length viral DNA and p24 production. (ii) When CD25- CD4+ cells are first purified from peripheral blood mononuclear cells and then incubated with HIV-1, viral DNA cannot be detected, suggesting that these purified cells cannot be infected. Furthermore, CD25-adherent cells do not facilitate the infection of CD4+ CD25- T cells when they were present at the time of incubation with HIV-1. Taken together, these studies suggest either that (i) the CD25- cells containing incomplete DNA transcripts are derived from infected-activated CD25+ cells, which subsequently become CD25- or (ii) the presence of CD25+ cells is required for the infection of CD25- cells in vitro.

Citing Articles

HIV specific Th1 responses are altered in Ugandans with HIV and Schistosoma mansoni coinfection.

Obuku A, Lugemwa J, Abaasa A, Joloba M, Ding S, Pollara J BMC Immunol. 2023; 24(1):25.

PMID: 37644394 PMC: 10466713. DOI: 10.1186/s12865-023-00554-3.


Modular Approaches to Understand the Immunobiology of Human Immunodeficiency Virus Latency.

Wolf G, Singh N Viral Immunol. 2021; 34(6):365-375.

PMID: 33600238 PMC: 8392075. DOI: 10.1089/vim.2020.0171.


CD25+ FoxP3+ Memory CD4 T Cells Are Frequent Targets of HIV Infection In Vivo.

Chachage M, Pollakis G, Kuffour E, Haase K, Bauer A, Nadai Y J Virol. 2016; 90(20):8954-67.

PMID: 27384654 PMC: 5044822. DOI: 10.1128/JVI.00612-16.


Sequential Dysfunction and Progressive Depletion of Candida albicans-Specific CD4 T Cell Response in HIV-1 Infection.

Liu F, Fan X, Auclair S, Ferguson M, Sun J, Soong L PLoS Pathog. 2016; 12(6):e1005663.

PMID: 27280548 PMC: 4900544. DOI: 10.1371/journal.ppat.1005663.


HIV Susceptibility of human antigen-specific CD4 T cells in AIDS pathogenesis and vaccine response.

Hu H, Liu F, Kim J, Ratto-Kim S Expert Rev Vaccines. 2016; 15(6):709-17.

PMID: 26814372 PMC: 4955395. DOI: 10.1586/14760584.2016.1147354.


References
1.
Thiele D, Kurosaka M, Lipsky P . Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester. J Immunol. 1983; 131(5):2282-90. View

2.
Loetscher P, Seitz M, Baggiolini M, Moser B . Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J Exp Med. 1996; 184(2):569-77. PMC: 2192704. DOI: 10.1084/jem.184.2.569. View

3.
Zagury D, Bernard J, Leonard R, Cheynier R, Feldman M, SARIN P . Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science. 1986; 231(4740):850-3. DOI: 10.1126/science.2418502. View

4.
Brown P, Bowerman B, Varmus H, Bishop J . Correct integration of retroviral DNA in vitro. Cell. 1987; 49(3):347-56. DOI: 10.1016/0092-8674(87)90287-x. View

5.
Koyanagi Y, Miles S, Mitsuyasu R, Merrill J, Vinters H, Chen I . Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science. 1987; 236(4803):819-22. DOI: 10.1126/science.3646751. View